Evidence map›Paper›PMID 30239622›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Increased Relative Abundance of Klebsiella pneumoniae Carbapenemase-producing Klebsiella pneumoniae Within the Gut Microbiota Is Associated With Risk of Bloodstream Infection in Long-term Acute Care Hospital Patients.

Teppei Shimasaki, Anna Seekatz, Christine Bassis, Yoona Rhee, Rachel D Yelin, Louis Fogg, Thelma Dangana, Enrique Cornejo Cisneros, Robert A Weinstein, Koh Okamoto and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 131 citations in OpenAlex.

  1. Trial
  2. Article
  3. The intestinal microbiota impacts nutritional immunity and resistance toProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Microbiota and kidney disease: the road ahead.Nature reviews. Nephrology · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 3 countries.

Teppei ShimasakiDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois.
Anna SeekatzDepartment of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor.
Christine BassisDepartment of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor.
Yoona RheeDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois.
Rachel D YelinDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois.
Louis FoggDepartment of Nursing, Rush University Medical Center, Chicago, Illinois.
Thelma DanganaDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois.
Enrique Cornejo CisnerosDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois.
Robert A WeinsteinDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois.
Koh OkamotoDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois.
Karen LolansDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois.
Michael SchoenyDepartment of Nursing, Rush University Medical Center, Chicago, Illinois.
Michael Y LinDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois.
Nicholas M MooreDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois.
Vincent B YoungDepartment of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor.
Mary K HaydenDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois.
Centers for Disease Control and Prevention Epicenters Program
Rush University Medical Center · USUniversity of Michigan · US

Funding

Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Systems biology of Clostridium difficile infectionU01AI124255 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHLOSS, PATRICK DAVID, YOUNG, VINCENT B · 2016 to 2020
$9.8M
Diversity and stability relationships in the murine microbiomeR01GM099514 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHLOSS, PATRICK DAVID · 2012 to 2015
$1.4M
Development of reproducible informatics skills among microbiome researchersR25GM116149 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHLOSS, PATRICK DAVID · 2015 to 2016
$148k
ACL HHS U54CK000481NCATS NIH HHS UL1 TR000433NCATS NIH HHS UL1 TR002240NCEZID CDC HHS U54 CK000481NCEZID CDC HHS U54 CK000607NIAID NIH HHS U01 AI124255NIGMS NIH HHS R01 GM099514NIGMS NIH HHS R25 GM116149
6 · The paper itself

Abstract

backgroundAn association between increased relative abundance of specific bacterial taxa in the intestinal microbiota and bacteremia has been reported in some high-risk patient populations.

methodsWe collected weekly rectal swab samples from patients at 1 long-term acute care hospital (LTACH) in Chicago from May 2015 to May 2016. Samples positive for Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) by polymerase chain reaction and culture underwent 16S rRNA gene sequence analysis; relative abundance of the operational taxonomic unit containing KPC-Kp was determined. Receiver operator characteristic (ROC) curves were constructed using results from the sample with highest relative abundance of KPC-Kp from each patient admission, excluding samples collected after KPC-Kp bacteremia. Cox regression analysis was performed to evaluate risk factors associated with time to achieve KPC-Kp relative abundance thresholds calculated by ROC curve analysis.

resultsWe collected 2319 samples from 562 admissions (506 patients); KPC-Kp colonization was detected in 255 (45.4%) admissions and KPC-Kp bacteremia in 11 (4.3%). A relative abundance cutoff of 22% predicted KPC-Kp bacteremia with sensitivity 73%, specificity 72%, and relative risk 4.2 (P = .01). In a multivariable Cox regression model adjusted for age, Charlson comorbidity index, and medical devices, carbapenem receipt was associated with achieving the 22% relative abundance threshold (P = .044).

conclusionCarbapenem receipt was associated with increased hazard for high relative abundance of KPC-Kp in the gut microbiota. Increased relative abundance of KPC-Kp was associated with KPC-Kp bacteremia. Whether bacteremia arose directly from bacterial translocation or indirectly from skin contamination followed by bloodstream invasion remains to be determined.

Indexed as

BacteremiaGastrointestinal MicrobiomeAdultAgedAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsCross InfectionFemaleHospitalsHumansKlebsiella InfectionsKlebsiella pneumoniaeLongitudinal StudiesMaleAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsbloodstream infectioncarbapenemase-producing Klebsiella pneumoniaeintestinal dominationlong-term acute care hospitalmicrobiome

Identifiers

PMID30239622
PMCPMC6541703
OpenAlexW2890084702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.